[1]
N. A. Awad, N. Y. Yassen, A. T. Tawfeeq, and K. M. Turki, “Hybrid nanoliposome as a targeted growth inhibitor for Cervical Carcinoma Cell line”, JFacMedBagdad, vol. 57, no. 4, pp. 320–324, Jan. 2016, doi: 10.32007/jfacmedbagdad.574399.